A study to evaluate if a new drug is effective in preventing the progression of lung fibrosis

Update Il y a 4 ans
Reference: EUCTR2012-001571-36

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is: To determine the effect of GS-6624 on progression free survival (PFS) as determined by either a categorical decline in forced vital capacity (FVC) and all cause mortality, in all subjects enrolled or in a subset of subjects who are classified as Lysyl Oxidase-like-2 (LOXL2) High based on a pre-specified level in serum at baseline.


Inclusion criteria

  • Idiopathic pulmonary fibrosis